60 Degrees Pharmaceuticals announces annual shareholder meeting

• 60 Degrees Pharmaceuticals will hold its 2026 annual shareholder meeting in a virtual, telephone-only format on Aug. 5, 2026.
• Shareholders will vote on electing five directors, including adding Eric Francois to the board.
• Other items include expanding the 2022 equity plan by 800,000 shares, plus authorizing a reverse stock split at a 1:5 to 1:10 ratio.
• Investors will also vote on a management success fee tied to a change of control, strategic transaction, or sale of Arakoda.
• Additional matters include ratifying RBSM as auditor, plus a possible meeting adjournment to seek more votes on key proposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-066363), on June 08, 2026, and is solely responsible for the information contained therein.